To determine if SIRT3 assists DLBCL cells to resists metabolic stress, we first determined expression of SIRT1, SIRT3 and ATM in human lymphoma samples to understand clinical relevance of these markers in DLBCL. This evidence concerns the gene SIRT3 and lymphoma.